Small Molecules that Correct RNA Splicing
At Skyhawk Therapeutics we use proprietary structural, kinetic, and computational models to invent small molecules that correct splicing in RNA, targeting some of the world's most intractable diseases
PARTNERS








WHAT WE DO
Our proprietary small molecule platform targets accelerates the discovery and development of drugs that correct RNA mis-splicing across a broad range of disease types:
ONCOLOGY
NEUROLOGY
INFLAMMATORY
INFECTIOUS
RARE
NEUROMUSCULAR
& METABOLIC
